Global quantitative mass spectrometry-based phosphoproteomics of FGFR2-fusion+ ICC cells further highlighted links between FGFR2 signaling and regulation of the NF-κB pathway. This evidence concerns the gene NFKB1 and intrahepatic cholangiocarcinoma.